Prescription Discount Card

A prescription discount card is a card, coupon or app that entitles the holder to a pre-negotiated cash price on a prescription at participating pharmacies. The operator negotiates prices with pharmacy networks in advance, usually through a pharmacy benefit manager, and the card holder pays that price directly at the counter. It is not insurance and not a health plan: there is no premium, no pooled risk, no deductible, no annual out-of-pocket limit, and no claims process to appeal to. What the card does is set a price on a transaction; everything else that a drug plan does, it does not do.

The reason a discount card price can be lower than an insured copay is that the two numbers come from different contracts. A copay is a term of your plan's benefit design. A card price is a term of the operator's contract with the pharmacy network. Neither is a discount off the other, and neither is "the real price"; they are simply two prices the same pharmacy has agreed to accept for the same drug under two different arrangements.

The pharmacy runs one route or the other. A prescription is submitted either through the drug plan, which produces plan cost sharing, or as a cash transaction under the card, which produces a cash price. The two routes are alternatives for a single fill, and pharmacies process both kinds of transaction every day, which is the arrangement 42 U.S.C. 1395w-104(m) presupposes when it protects a pharmacist's ability to point out the cheaper one. The consequence to hold on to is that a card purchase is a purchase the plan never sees.

That is where the consequence lives, and it is statutory rather than contractual. For Medicare Part D, what counts toward the annual out-of-pocket threshold is defined at 42 U.S.C. 1395w-102(b)(4)(C)(i), which says incurred costs "shall only include costs incurred with respect to covered part D drugs for the annual deductible ..., for cost-sharing ..., but does not include any costs incurred for covered part D drugs which are not included (or treated as being included) in the plan's formulary". A cash purchase generates neither a plan deductible payment nor plan cost sharing, so there is nothing for that paragraph to pick up.

Read what the exceptions list leaves out, not just what it contains. Subparagraph (C)(iii) is a closed list of payments that are treated as incurred even though someone else made them: the low-income subsidy under 42 U.S.C. 1395w-114, a State Pharmaceutical Assistance Program, the Indian Health Service, an Indian tribe or tribal organization or an urban Indian organization, an AIDS Drug Assistance Program, and payments under 42 U.S.C. 1395w-115(h). Commercial discount cards appear nowhere in it. The contrast with Extra Help is the clean one: two ways of paying less at the counter, one of which Congress wrote into the count and one of which it did not.

Congress has legislated on the existence of the cheaper cash price, which is the strongest evidence that it is a real phenomenon rather than a marketing claim. 42 U.S.C. 1395w-104(m) requires a Part D sponsor to ensure its plans do not restrict a pharmacy, or penalize a pharmacy, for "informing ... an enrollee in such plan of any differential between the negotiated price of, or copayment or coinsurance for, the drug or biological to the enrollee under the plan and a lower price the individual would pay for the drug or biological if the enrollee obtained the drug without using any health insurance coverage." In plain terms: the pharmacist is allowed to tell you when paying cash is cheaper, and the plan may not stop them.

Why the same intermediaries sit on both sides. The FTC's July 2024 interim staff report on pharmacy benefit managers found that vertical integration and concentration have left the six largest pharmacy benefit managers managing nearly 95 percent of all prescriptions filled in the United States. The same small set of firms therefore stands behind the plan's negotiated price and, frequently, behind the card's cash price too. That is worth knowing because it explains how two very different numbers can be attached to one drug at one pharmacy without either being an error.

The decision rule that follows. A card is most useful when the plan is contributing nothing anyway: while the deductible is unmet, on a drug the plan's formulary does not cover, or where the cash price is simply lower than the copay on a cheap generic drug. It becomes a bad trade for someone who expects to reach the annual out-of-pocket threshold in a given year, because every dollar spent on the card is a dollar that does not advance them toward the point where the plan pays everything. And for a drug the plan does not cover at all, note that the statute excludes non-formulary spending from the count whichever way it is paid, so the card costs nothing in progress there.

What the card is not. It carries no appeal rights, no coverage determination, no exception process, and no guarantee that a price stays available. Prices change without notice and vary by pharmacy for the same drug on the same day, so a card price is a quote rather than a benefit.

1. The operator negotiates in advance. Working through a pharmacy benefit manager, the card operator agrees prices with pharmacy chains and independents for a long list of drugs.

2. You look up your drug and your pharmacy. Prices differ by pharmacy and by drug, and they change, so the number is a current quote rather than a fixed benefit.

3. You present the card instead of your plan card. The pharmacy processes the fill as a cash transaction at the card's price.

4. Nothing reaches your plan. No claim is submitted, so no deductible payment and no cost sharing is recorded, and nothing counts toward an annual out-of-pocket total.

5. You decide again next fill. Nothing is locked in, and the answer can be different next month or at a different pharmacy.

A hypothetical. Owen has Medicare drug coverage and has not yet met his plan's deductible for the year. His pharmacy quotes $92 for a 30-day supply through the plan, and a discount card price of $19 for the same fill. He takes the $19, saving $73 that month. But because the fill went through as cash, none of it counts toward the annual out-of-pocket threshold that would eventually drop his cost sharing to nothing for the rest of the year.

Whether that trade is good depends on his year. If this is his only prescription and he was never going to reach the threshold, the $73 is simply $73. If he also takes a specialty drug that will carry him to the threshold by, say, September, then paying the $92 through the plan would have moved him $92 closer, and the $73 he saved in one month is bought at the price of arriving at full coverage a little later. Figures are illustrative; the actual deductible and threshold are set annually and are published on medicare.gov.

Pros

• It costs the holder nothing, so it can be kept in reserve and checked against the plan price fill by fill.
• It frequently beats a copay on inexpensive generics and on drugs the plan does not cover.
• It is the obvious route while a deductible is unmet, when the plan is contributing nothing to the fill anyway.
• It works for someone with no drug coverage at all, and for a drug excluded from a formulary.
• Federal law protects the pharmacist's ability to tell a Part D enrollee when the cash price is lower.

Cons

• It is not insurance. There is no cap on annual spending, no appeal, no coverage determination and no exception process.
• For Medicare Part D, spending on the card does not count toward the annual out-of-pocket threshold, so it can delay the point at which the plan starts paying everything.
• Prices vary by pharmacy and change without notice, so a saving found once is not a saving you can rely on.
• Comparing prices takes work at every fill, which is a real cost for someone managing several medicines.
• Because the fill never reaches the plan, the plan's records do not show it, which can complicate a later coverage or interaction review.